Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 3546 entries
View as:

A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01495065 Org: User:
Start: 12/19/11 End: 02/17/12 Due: 02/17/13

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Phase: N/A Priority: Normal
NCT ID: NCT03629886 Org: User:
Start: 08/22/18 End: 02/28/20 Due: 02/28/21

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00359463 Org: User:
Start: 04/18/06 End: 03/07/07 Due: 03/07/08

An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01466335 Org: User:
Start: 10/27/11 End: 03/05/12 Due: 03/05/13

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

Phase: N/A Priority: Normal
NCT ID: NCT00169546 Org: User:
Start: 01/31/03 End: 12/31/05 Due: 12/31/06

Fondaparinux EU-RMP (Adherence)

Phase: N/A Priority: Normal
NCT ID: NCT01406301 Org: User:
Start: 03/31/08 End: 07/31/11 Due: 07/31/12

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00369824 Org: User:
Start: 09/26/06 End: 02/13/08 Due: 02/13/09

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

Phase: N/A Priority: Normal
NCT ID: NCT05334368 Org: User:
Start: 09/06/22 End: 11/30/26 Due: 11/30/27

A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.

Phase: N/A Priority: Normal
NCT ID: NCT01039610 Org: User:
Start: 11/30/09 End: 08/31/10 Due: 08/31/11

Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians

Phase: N/A Priority: Normal
NCT ID: NCT01777074 Org: User:
Start: 11/30/09 End: 04/30/12 Due: 04/30/13

The Effect of Experimental Dentifrices on Remineralization of Caries Lesions In-situ

Phase: N/A Priority: Normal
NCT ID: NCT02195583 Org: User:
Start: 06/30/14 End: 08/31/14 Due: 08/31/15

COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00113308 Org: User:
Start: 06/30/05 End: 09/30/06 Due: 09/30/07

A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01332552 Org: User:
Start: 01/14/11 End: 04/06/11 Due: 04/06/12

Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT00085904 Org: User:
Start: 04/30/04 End: - Due: -

AVODART(Dutasteride) Post-marketing Surveillance(PMS)

Phase: N/A Priority: Normal
NCT ID: NCT01299571 Org: User:
Start: 12/31/04 End: 07/31/10 Due: 07/31/11

Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years

Phase: N/A Priority: Normal
NCT ID: NCT00616928 Org: User:
Start: 01/23/08 End: 03/19/09 Due: 03/19/10

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Phase: N/A Priority: Normal
NCT ID: NCT00363727 Org: User:
Start: 12/31/03 End: 01/31/06 Due: 01/31/07

A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD

Phase: N/A Priority: Normal
NCT ID: NCT01636713 Org: User:
Start: 07/31/12 End: 10/31/13 Due: 10/31/14

Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin

Phase: N/A Priority: Normal
NCT ID: NCT00411190 Org: User:
Start: 10/19/06 End: 12/15/06 Due: 12/15/07

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Phase: N/A Priority: Normal
NCT ID: NCT00289198 Org: User:
Start: 02/07/06 End: 07/04/06 Due: 07/04/07

Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT01357876 Org: User:
Start: 10/01/10 End: 07/07/11 Due: 07/07/12

Observational Study of Nelarabine in Children and Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT00866671 Org: User:
Start: 02/28/09 End: 09/30/14 Due: 09/30/15

Bioequivalence Trial of Alprazolam 0.25 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01853956 Org: User:
Start: 12/02/10 End: 12/10/10 Due: 12/10/11

Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00379977 Org: User:
Start: 09/30/06 End: 12/31/06 Due: 12/31/07

Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT00353873 Org: User:
Start: 11/18/05 End: 10/26/06 Due: 10/26/07